Business
Press Release Feb 24 2026
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP "
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24, 2026, titled \"Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP \" View Attachment","length":397,"tagName":"div"}]